Document is current
Any future updates will be listed below
-
Authors
Asquier-Khati, Antoine https://orcid.org/0000-0001-7745-2302
Mauhin, Wladimir
Michel, Guillaume
Gendre, Adrien
Durant, Cécile
Lavigne, Christian
Maillard, Hélène
Lacombe, Didier
Willems, Marjolaine
Lidove, Olivier
Masseau, Agathe
- License Information
-
More Information
Article History
Received: 19 June 2021
Accepted: 3 November 2021
First Online: 26 November 2021
Declarations
:
: WM and OL received travel fees or speaking honoraria from Shire-Takeda, Amicus Therapeutics and Sanofi-Genzyme. CL received travel fees or speaking honoraria from Sanofi-Genzyme. HM received travel fees or speaking honoraria from Shire-Takeda, Amicus Therapeutics and Sanofi-Genzyme. DL received travel fees or board or speaking honoraria from Shire-Takeda, Amicus Therapeutics and Sanofi-Genzyme.
: Written informed consent was obtained when patients were included in the FFABRY cohort. An information sheet was sent to patients when adding ENT to FFABRY register.
: All authors have read the final version of the manuscript and agree with its publication.
